HBW InsightOcuSoft Inc. announced after recently launching Retaine MGD Advanced lubricant eye drops that a product made with the original Retaine formulation available under a different brand from Bruder Healthc
Medtech InsightOlympus Corporation is over halfway through its five-year corporate strategy, set in 2019, by the end of which it will be growing at rate of 5-6% annually and making an operating margin of over 20%.
In VivoOlympus Corporation is over halfway through its five-year corporate strategy, set in 2019, by the end of which it will be growing at rate of 5-6% annually and making an operating margin of over 20%.
ScripJapan has granted the first approval worldwide for a Janus kinase (JAK) inhibitor in topical form, issuing a nod for Japan Tobacco Inc. ’s Corectim (delgocitinib; JTE-052) in the second-line treatmen